| 标题 |
BL-B01D1, a first-in-class EGFR-HER3 bispecific antibody-drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet. Oncology 作者:Ma Y; Huang Y; Zhao Y; Zhao S; Xue J; et al 出版日期:2024/07/01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)